Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). (Q46537565)
Jump to navigation
Jump to search
scientific article published on 9 June 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). |
scientific article published on 9 June 2005 |
Statements
1 reference
Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). (English)
1 reference
1 reference
S Chua
1 reference
I E Smith
1 reference
R P A'Hern
1 reference
G A Coombes
1 reference
T F Hickish
1 reference
A C Robinson
1 reference
R W Laing
1 reference
M E R O'Brien
1 reference
S R Ebbs
1 reference
A Hong
1 reference
T Mughal
1 reference
M Verrill
1 reference
D Dubois
1 reference
J M Bliss
1 reference
TOPIC Trial Group
1 reference
9 June 2005
1 reference
1 reference
16
1 reference
1435-1441
1 reference
9
1 reference
Identifiers
1 reference
1 reference